Psychosis in Parkinson’s Disease: Current Treatment Options and Impact on Patients and Caregivers
Authors:
Open Access
- 5 July 2021
- journal article
- review article
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
- Vol. 34 (4) , 274-279
Abstract
Parkinson’s disease (PD) is the second most common neurodegenerative disease seen in older adults after Alzheimer’s disease, with increasing prevalence worldwide. Parkinson’s disease psychosis (PDP) is a common, non-motor feature of PD, which increases caregiver stress and is a risk-factor for nursing home placement. In this paper we review PDP epidemiology, features, diagnosis, and treatment. PDP most often presents with sequential development of minor and then increasingly complex visual hallucinations mediated by dopaminergic-serotonergic interactions activating the mesolimbic pathway, with contributions from other structures and neurotransmitters. Appropriate evaluation of differential diagnoses for psychosis is vital before diagnosing PDP. Initial treatment should involve non-pharmacologic approaches. If these are unsuccessful and PDP symptoms significantly impact the patient’s and or their caregivers’ quality of life and functions, then pharmacotherapy is indicated. Pimavanserin is a recently FDA-approved pharmacologic treatment for PDP with a better profile of balanced effectiveness and safety compared to previous use of atypical antipsychotics. Early diagnosis and safer, more effective treatments for PDP should help reduce caregiver burden and enable caregivers to continue to provide care at home versus institutionalization.Keywords
This publication has 47 references indexed in Scilit:
- Scales to assess psychosis in Parkinson's disease: Critique and recommendationsMovement Disorders, 2008
- Presentation and Management of Psychosis in Parkinson’s Disease and Dementia With Lewy BodiesAmerican Journal of Psychiatry, 2007
- Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work groupMovement Disorders, 2007
- Rater-blinded, Prospective ComparisonClinical Neuropharmacology, 2006
- Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disabilityParkinsonism & Related Disorders, 2006
- Epidemiology of and Risk Factors for Psychosis of Alzheimer’s Disease: A Review of 55 Studies Published From 1990 to 2003American Journal of Psychiatry, 2005
- Psychosis in Parkinson’s diseasePostgraduate Medical Journal, 2005
- Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobeBrain, 2002
- Visual hallucinations in Parkinson's disease: a review and phenomenological surveyJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's DiseaseNew England Journal of Medicine, 1999